Ghana receives €2m for vaccine, pharmaceutical innovation
Eight research projects have received grants totalling €2 million under the PharmaVax Ghana programme to advance vaccine and pharmaceutical innovation and strengthen local manufacturing capacity. The post Ghana receives €2m for vaccine, pharmaceutical innovation appeared first on Ghana Business News .
Ghana has received €2 million in funding for vaccine and pharmaceutical innovation through the PharmaVax Ghana programme. The initiative, co-hosted by the National Vaccine Institute and Deutsche Gesellschaft für Internationale Zusammenarbeit, was presented at a "Research Meets Manufacturing" award ceremony in Accra on August 19, 2026.
The grants will support eight research projects led by Ghanaian research institutions and pharmaceutical companies, aiming to translate scientific discoveries into practical health products for Ghana and the wider African market. The projects cover a range of areas, including child-friendly malaria medicines, herbal treatments for chronic diseases, vaccine stability and production, snake venom antiserum, and the use of artificial intelligence to accelerate antibody and diagnostic development for malaria and Mpox.
The initiative is jointly funded by the German Federal Ministry for Economic Cooperation and Development and the European Union, with Ghanaian partners contributing an additional €425,000.
Brief written by urgent.news from Ghana Business News's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
